BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31306619)

  • 1. Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature.
    Ababou M; Mahtat EM; Jennane S; Elmaaroufi H; Mikdame M; Doghmi K
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):153-155. PubMed ID: 31306619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
    Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
    Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier.
    Fujimoto K; Endo T; Nishio M; Obara M; Yamaguchi K; Takeda Y; Goto H; Kasahara I; Sato N; Koike T
    Int J Hematol; 2009 Dec; 90(5):601-604. PubMed ID: 19802732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of splenic marginal zone lymphoma in a patient treated for hepatitis B: a case of HBV-associated lymphoma.
    Koot AW; Visscher AP; Huits RM
    Acta Clin Belg; 2015 Aug; 70(4):301-3. PubMed ID: 25977147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
    Sima A; Hollander P; Baecklund E; Smedby KE; Enblad G; Amini RM
    Br J Haematol; 2021 Aug; 194(3):568-579. PubMed ID: 34109612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
    Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
    Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possible contribution of disseminated Mycobacterium shigaense infection to development of splenic marginal zone lymphoma].
    Hatsuse M; Daikoku Y; Taminishi Y; Fuchida SI; Takemura Y; Okano A; Murakami S; Shimazaki C
    Rinsho Ketsueki; 2018; 59(7):878-883. PubMed ID: 30078797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
    Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
    Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma.
    Fodor A; Molnar MZ; Krenacs L; Bagdi E; Csomor J; Matolcsy A; Demeter J
    Pathol Oncol Res; 2009 Dec; 15(4):597-603. PubMed ID: 19343544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
    Lenglet J; Traullé C; Mounier N; Benet C; Munoz-Bongrand N; Amorin S; Noguera ME; Traverse-Glehen A; Ffrench M; Baseggio L; Felman P; Callet-Bauchu E; Brice P; Berger F; Salles G; Brière J; Coiffier B; Thieblemont C
    Leuk Lymphoma; 2014 Aug; 55(8):1854-60. PubMed ID: 24206091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic Marginal Zone Lymphoma with Acquired von Willebrand Syndrome Diagnosed via Splenic Bleeding.
    Komeno Y; Shibuya N; Uryu H; Yamada H; Toda T; Shibasaki M; Kunishima S; Iihara K; Ryu T
    Intern Med; 2017; 56(5):557-562. PubMed ID: 28250305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Splenic marginal zone lymphoma].
    Dimopoulos K; Pedersen M
    Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
    Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Sachanas S; Angelopoulou MK
    Leuk Lymphoma; 2014 Jul; 55(7):1463-70. PubMed ID: 24050506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic marginal zone lymphoma: from genetics to management.
    Arcaini L; Rossi D; Paulli M
    Blood; 2016 Apr; 127(17):2072-81. PubMed ID: 26989207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study.
    Okay M; Aslan T; Özdemir E; Üner A; Sağlam A; Güngör E; Uysal A; Alayvaz Aslan N; Yıldızhan E; Ağıt A; Dal MS; Korkmaz S; Namdaroğlu S; Sivgin S; Akgün Çağlıyan G; Demircioğlu S; Barışta İ; Özhamam E; Vural F; Eser B; Özet G; Yıldırım R; Doğu MH; Berber İ; Erkurt MA; Malkan ÜY; Altuntaş F; Büyükaşık Y
    Turk J Haematol; 2020 May; 37(2):84-90. PubMed ID: 31630512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic marginal zone lymphoma in a patient with chronic hepatitis B.
    Christou L; Kalambokis G; Bai M; Kamina S; Tsianos EV
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):511-2. PubMed ID: 20076834
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between splenic marginal zone B-cell lymphoma and chronic liver disease associated with hepatitis C virus infection.
    Moccia F; Tognoni E; Boccaccio P
    Ann Ital Med Int; 1999; 14(4):288-93. PubMed ID: 10638021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic marginal zone lymphoma leads to sinistral portal hypertension.
    Lv XH; Ma LL; Fu WY; Xie Y
    J Dig Dis; 2019 Jan; 20(1):45-48. PubMed ID: 30549195
    [No Abstract]   [Full Text] [Related]  

  • 20. No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.
    Kalpadakis C; Pangalis GA; Sachanas S; Rontogianni D; Korkolopoulou P; Milionis V; Vassilakopoulos TP; Papadaki HA; Angelopoulou MK
    Leuk Lymphoma; 2016 Nov; 57(11):2705-8. PubMed ID: 27082039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.